Cargando…
Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
BACKGROUND: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. CASE SUMMARY: This...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879840/ https://www.ncbi.nlm.nih.gov/pubmed/36727127 http://dx.doi.org/10.1093/ehjcr/ytad013 |
_version_ | 1784878777273155584 |
---|---|
author | Kashyap, Niharika Nikhanj, Anish Gagnon, Luke R Moukaskas, Basel Siddiqi, Zaeem A Oudit, Gavin Y |
author_facet | Kashyap, Niharika Nikhanj, Anish Gagnon, Luke R Moukaskas, Basel Siddiqi, Zaeem A Oudit, Gavin Y |
author_sort | Kashyap, Niharika |
collection | PubMed |
description | BACKGROUND: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. CASE SUMMARY: This study closely followed four adult patients from the Neuromuscular Multidisciplinary Clinic (Alberta, Canada) that presented with X-linked recessive EDMD. Patients were assessed and managed on a case-by-case basis. Clinical status and cardiac function were assessed through clinical history, physical examination, and investigations (12-lead electrocardiogram, 24 hour Holter monitor, transthoracic echocardiogram, and plasma biomarkers). Conduction disease, requiring permanent pacemaker, was prevalent in all patients. With appropriate medical therapy over a median follow-up period five years the cardiac status was shown to have stabilized in all these patients. DISCUSSION: We demonstrate the presentation of arrhythmias, conduction abnormalities, and chamber dilation in adult patients with X-linked EDMD. Cardiac medications and pacemaker therapy are shown to prevent adverse outcomes from these complications. Patients with EDMD are expected to develop heart disease early and prior to the development of an overt neuromuscular phenotype. These patients should be closely monitored in a multidisciplinary setting for effective management to improve their clinical outcomes. |
format | Online Article Text |
id | pubmed-9879840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98798402023-01-31 Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series Kashyap, Niharika Nikhanj, Anish Gagnon, Luke R Moukaskas, Basel Siddiqi, Zaeem A Oudit, Gavin Y Eur Heart J Case Rep Case Series BACKGROUND: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. CASE SUMMARY: This study closely followed four adult patients from the Neuromuscular Multidisciplinary Clinic (Alberta, Canada) that presented with X-linked recessive EDMD. Patients were assessed and managed on a case-by-case basis. Clinical status and cardiac function were assessed through clinical history, physical examination, and investigations (12-lead electrocardiogram, 24 hour Holter monitor, transthoracic echocardiogram, and plasma biomarkers). Conduction disease, requiring permanent pacemaker, was prevalent in all patients. With appropriate medical therapy over a median follow-up period five years the cardiac status was shown to have stabilized in all these patients. DISCUSSION: We demonstrate the presentation of arrhythmias, conduction abnormalities, and chamber dilation in adult patients with X-linked EDMD. Cardiac medications and pacemaker therapy are shown to prevent adverse outcomes from these complications. Patients with EDMD are expected to develop heart disease early and prior to the development of an overt neuromuscular phenotype. These patients should be closely monitored in a multidisciplinary setting for effective management to improve their clinical outcomes. Oxford University Press 2023-01-11 /pmc/articles/PMC9879840/ /pubmed/36727127 http://dx.doi.org/10.1093/ehjcr/ytad013 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Series Kashyap, Niharika Nikhanj, Anish Gagnon, Luke R Moukaskas, Basel Siddiqi, Zaeem A Oudit, Gavin Y Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series |
title | Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series |
title_full | Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series |
title_fullStr | Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series |
title_full_unstemmed | Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series |
title_short | Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series |
title_sort | cardiac manifestations and clinical management of x-linked emery-dreifuss muscular dystrophy: a case series |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879840/ https://www.ncbi.nlm.nih.gov/pubmed/36727127 http://dx.doi.org/10.1093/ehjcr/ytad013 |
work_keys_str_mv | AT kashyapniharika cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries AT nikhanjanish cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries AT gagnonluker cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries AT moukaskasbasel cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries AT siddiqizaeema cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries AT ouditgaviny cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries |